Results 111 to 120 of about 165,954,653 (289)
Diode Laser Photocoagulation in the Treatment of Retinopathy of Prematurity
Purpose: To make a data analysis of cases with retinopathy of prematurity that underwent diode laser photocoagulation (DLPC) treatment. Material and Method: Files of 52 ROP cases treated with DLPC between November 2011 and November 2012 were ...
Hüseyin Yetik +2 more
core +1 more source
Abstract To identify, describe and critically appraise studies developing and/or validating models for predicting sight‐threatening retinopathy of prematurity (ROP) in preterm infants undergoing screening in neonatal intensive care units. PubMed, Embase via Ovid, trial registers, and grey literature were searched from inception to 21 October 2025 ...
Stella Moutzouri +7 more
wiley +1 more source
Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
Samiksha Fouzdar Jain,1 Helen H Song,2 Shaza N Al-Holou,2 Linda A Morgan,1 Donny W Suh1,2 1Ophthalmology Department, Children’s Hospital and Medical Center, Omaha, NE, USA; 2Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, NE,
Fouzdar Jain S +4 more
core
Abstract Purpose Dexamethasone eye drops are being introduced off‐label to prevent progression of severe retinopathy of prematurity (ROP). We evaluated ophthalmologic outcomes in early childhood after postnatal topical dexamethasone exposure in pre‐term infants at a standardized follow‐up examination.
Mariya Petrishka‐Lozenska +3 more
wiley +1 more source
A case of retinopathy of prematurity treated by pattern scan laser photocoagulation
Satoshi Ota, Miho Nozaki, Shuichiro Hirahara, Tomoaki Hattori, Munenori Yoshida, Yuichiro Ogura Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan Abstract: We experienced a case of
Ota S +5 more
doaj
Fundoscopic evolution of premature newborns with retinopathy of prematurity treated with intravitreal antiangiogenics [PDF]
Objective: To determine the evolution of retinopathy of prematurity in patients treated with intravitreal antiangiogenics in the retina private practice. Methods: A retrospective descriptive observational case series study was conducted.
Camila Sofía Negrín +4 more
doaj +2 more sources
Current screening and treatments in retinopathy of prematurity in the US
Ana M Suelves, Julia P Shulman Department of Ophthalmology, New York Medical College, Valhalla, NY, USA Abstract: Retinopathy of prematurity (ROP) is a complex disease characterized by an aberrant developmental retinal angiogenesis in preterm infants ...
Shulman JP, Suelves AM
core
Abstract Purpose To develop THESS‐ROP, a novel prediction model for treatment‐warranted retinopathy of prematurity (TW‐ROP) and compare its performance with four established models in a Greek cohort of consecutively screened preterm infants. Methods This ambispective cohort study included all 526 infants screened for ROP (2016–2022) at the 2nd ...
Stella Moutzouri +6 more
wiley +1 more source
Retinopathy of Prematurity and MicroRNAs
Retinopathy of Prematurity (ROP), a leading cause of blindness in preterm infants, arises from dysregulated angiogenesis and inflammation. Without timely intervention, ROP can progress to severe outcomes, including dense fibrovascular plaques and retinal detachment.
Albanese, Giuseppe Maria +8 more
openaire +4 more sources
Clinical outcomes of the PAUL® glaucoma implant for secondary glaucoma
Abstract Purpose Secondary glaucoma encompasses a broad spectrum of disease entities arising from diverse ocular pathologies and is often refractory to conventional treatment. Glaucoma drainage devices (GDDs) have therefore become an important surgical option.
Carolin Deubel +7 more
wiley +1 more source

